MK-2214 clinical trials

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

This study is looking into a new medication called MK-2214 for people with early Alzheimer's disease. Researchers want to see if it can slow down changes in the brain that cause memory and thinking problems. They will also check if it's safe for people to take.